Philips, ResMed, & CAIRE Engage in Fierce Competition to Lead the U.S. Anesthesia, Respiratory, and Sleep Therapy Market

August 23, 2023 09:00 AM EDT | By EIN Presswire
 Philips, ResMed, & CAIRE Engage in Fierce Competition to Lead the U.S. Anesthesia, Respiratory, and Sleep Therapy Market
Image source: EIN Presswire

VANCOUVER, BC, CANADA, August 23, 2023/EINPresswire.com/ -- In the latest market report revision from iData Research, a globally acclaimed market research and consulting firm with expertise in medical devices and pharmaceuticals, a comprehensive analysis of the U.S. market for anesthesia, respiratory, and sleep therapy devices is presented. This report delves deeply into multiple sectors of this market, including anesthesia delivery units (ADUs), anesthesia monitors, anesthesia information management systems (AIMS), anesthesia disposables, ventilators, nebulizers, respiratory disposables, oxygen therapy devices, devices for therapeutic obstructive sleep apnea (sleep therapy), and sleep diagnostic devices.

Presently, the U.S. market for anesthesia, respiratory, and sleep management devices is experiencing a favorable influence from the ongoing demographic shifts within the United States. Projections indicate that by 2030, the American population aged 50 and above will reach 70 million, while nearly half of the entire populace will be grappling with obesity. These demographic factors are anticipated to foster a heightened demand for products related to anesthesia, respiratory care, and sleep apnea, consequently driving the expansion of the overall market encompassing these sectors. Furthermore, the evolution of technology will also play a pivotal role in propelling growth within the anesthesia, respiratory, and sleep management device market.

The most recent report from iData employs a comprehensive methodology to meticulously assess aspects such as market dimensions, unit sales, company market shares, and precise forecasts, ensuring a thorough and accurate analysis.

Key takeaways from iData's latest report include:

Steadfast Market Growth: The U.S. market for anesthesia, respiratory, and sleep therapy devices is poised for substantial growth, fueled by factors such as the increasing prevalence of respiratory disorders, advancements in medical technology, and the rising demand for efficient sleep therapy solutions. By 2029, the market is anticipated to reach an impressive $7.8 billion.

Technological Innovations: Technological advancements play a pivotal role in shaping the anesthesia, respiratory, and sleep therapy devices landscape. Innovations such as newer ventilators and ADUs are now controlled electronically and offer tremendous operational functionality and flexibility.

Global Inflation Rates: Between the years 2021 and 2022, the global inflation rates saw the most significant surge within a single year since the period of 1991-1992. Consequently, prices have escalated across various industries on a global scale, including the healthcare sector. This inflationary trend has notably affected numerous products within the realm of anesthesia, respiratory care, and sleep apnea. As a result, this phenomenon is poised to drive expansion within the broader markets encompassing anesthesia, respiratory solutions, and sleep apnea treatments.

Supply Chain Disruptions: Virtually every facet of the anesthesia, respiratory, and sleep (ARS) market experienced adverse effects due to disruptions in the supply chain. These disruptions were particularly evident in markets that relied on chips and other electrical components. The scarcity of chips, in particular, not only complicated the production of ARS products but also introduced a situation where companies within these sectors found themselves competing with industries external to their own.

Competitive Landscape: The report offers an insightful analysis of the competitive landscape, profiling key industry players and their strategic initiatives. Presently, Philips Healthcare and ResMed stand as prominent competitors in the U.S. anesthesia, respiratory and sleep management device market. Although Philips lost significant share in the obstructive sleep apnea market (OSA), the company was able to maintain its position by leading the anesthesia monitor market, the ventilator market, and the sleep diagnostics device market, while also having significant share in the oxygen therapy market.

As the U.S. healthcare landscape continues to evolve, the anesthesia, respiratory, and sleep therapy devices market is poised to play a pivotal role in enhancing patient care and medical outcomes. With an increasing emphasis on efficient respiratory and sleep therapy solutions, the adoption of advanced devices is set to soar, solidifying the market's upward trajectory.

For comprehensive insights into the U.S. Anesthesia, Respiratory, and Sleep Therapy Devices Market and access to the complete iData Research report, please visit:

https://idataresearch.com/product/anesthesia-respiratory-and-sleep-therapy-devices-market-united-states/.

About iData

iData Research stands as a leading market research and intelligence provider, offering comprehensive insights and meticulous data analysis across diverse industries. With a strong reputation and a proven track record, iData Research remains the preferred choice for businesses seeking informed decisions in today's dynamic market landscape.

Why Choose iData?

Wide Industry Coverage: iData Research offers extensive coverage across various industries, including healthcare, medical devices, dental, pharmaceuticals, biotechnology, and more. This breadth ensures clients from diverse sectors access accurate, up-to-date information tailored to their business objectives.

High-Quality Data: iData Research's success is rooted in its commitment to delivering high-quality data. Their expert analysts employ rigorous
methodologies to collect and analyze data from reliable sources, providing clients with accurate, insightful, and actionable information guiding strategic decisions.

Profound Analysis: Beyond data presentation, iData Research offers in-depth analysis that delves into industry trends, market dynamics, and competitive landscapes. Their reports provide a comprehensive understanding of market forces, helping clients identify opportunities and challenges.

Tailored Solutions: Recognizing each business's uniqueness, iData Research offers customizable solutions catering to specific client needs. Whether for startups or multinational corporations, their tailored offerings provide relevant insights to drive growth and success.

Timely Updates: Navigating the fast-paced business environment requires real-time information. iData Research ensures clients access the latest data and insights, enabling agile decisions and swift adaptation to market changes.

Global Perspective: In an interconnected world, a global perspective is indispensable. iData Research's reports offer insights into various geographic markets, empowering clients to make informed decisions regardless of their business's location.

Trusted by Industry Leaders: The trust placed in iData Research by industry leaders and renowned companies attests to the quality of their services. Their client list includes major players who rely on their insights for strategic planning.

Emma Matrick
iData Research
7785493830 ext.
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Incorporated (Kalkine Media), Business Number: 720744275BC0001 and is available for personal and non-commercial use only. The advice given by Kalkine Media through its Content is general information only and it does not take into account the user’s personal investment objectives, financial situation and specific needs. Users should make their own enquiries about any investment and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary. Kalkine Media is not registered as an investment adviser in Canada under either the provincial or territorial Securities Acts. Some of the Content on this website may be sponsored/non-sponsored, as applicable, however, on the date of publication of any such Content, none of the employees and/or associates of Kalkine Media hold positions in any of the stocks covered by Kalkine Media through its Content. Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used in the Content are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used in the Content unless stated otherwise. The images/music that may be used in the Content are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated or was found to be necessary.


Sponsored Articles


Investing Ideas

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.